KOSS Koss Corp
Price (delayed)
$5.99
Market cap
$56.16M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.08
Enterprise value
$53.63M
Predictive Oncology operates through three segments (Skyline, Helomics and Soluble Biotech), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data
Highlights
Koss's EPS has increased by 33% from the previous quarter and by 27% YoY
Koss's net income has increased by 33% from the previous quarter and by 26% YoY
The quick ratio has declined by 28% year-on-year but it is up by 17% since the previous quarter
KOSS's revenue is down by 7% year-on-year
Key stats
What are the main financial stats of KOSS
Market
Valuations
Earnings
Shares outstanding
9.38M
Market cap
$56.16M
Enterprise value
$53.63M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.81
Price to sales (P/S)
4.56
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.36
Revenue
$12.29M
Gross profit
$4.59M
Operating income
-$1.71M
Net income
-$749,542
EBIT
-$821,384
EBITDA
-$601,233
Free cash flow
-$375,484
Per share
Balance sheet
Liquidity
EPS
-$0.08
EPS diluted
-$0.08
Free cash flow per share
-$0.04
Book value per share
$3.31
Revenue per share
$1.31
TBVPS
$4
Total assets
$37.44M
Total liabilities
$6.44M
Debt
$0
Equity
$30.99M
Working capital
$15.05M
Debt to equity
0
Current ratio
9.97
Quick ratio
6.6
Net debt/EBITDA
4.22
Margins
Efficiency
Dividend
EBITDA margin
-4.9%
Gross margin
37.3%
Net margin
-6.1%
Operating margin
-13.9%
Return on assets
-2%
Return on equity
-2.4%
Return on invested capital
-2.5%
Return on capital employed
-2.3%
Return on sales
-6.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
KOSS stock price
How has the Koss stock price performed over time
Intraday
-3.07%
1 week
-8.69%
1 month
-10.33%
1 year
129.5%
YTD
-18.83%
QTD
-18.83%
Financial performance
How have Koss's revenue and profit performed over time
Revenue
$12.29M
Gross profit
$4.59M
Operating income
-$1.71M
Net income
-$749,542
Gross margin
37.3%
Net margin
-6.1%
Koss's net margin has increased by 34% QoQ and by 21% YoY
Koss's net income has increased by 33% from the previous quarter and by 26% YoY
KOSS's operating margin is up by 18% since the previous quarter and by 9% year-on-year
The operating income has grown by 16% from the previous quarter and by 15% YoY
Growth
What is Koss's growth rate over time
Valuation
What is Koss stock price valuation
P/E
N/A
P/B
1.81
P/S
4.56
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.36
Koss's EPS has increased by 33% from the previous quarter and by 27% YoY
KOSS's P/B is 33% below its 5-year quarterly average of 2.7 but 13% above its last 4 quarters average of 1.6
The stock's P/S is 20% above its 5-year quarterly average of 3.8 and 11% above its last 4 quarters average of 4.1
KOSS's revenue is down by 7% year-on-year
Efficiency
How efficient is Koss business performance
The company's return on equity rose by 33% QoQ and by 25% YoY
Koss's ROS has increased by 32% from the previous quarter and by 26% YoY
KOSS's ROIC is up by 31% QoQ and by 29% YoY
Koss's ROA has increased by 31% from the previous quarter and by 23% YoY
Dividends
What is KOSS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for KOSS.
Financial health
How did Koss financials performed over time
The quick ratio has declined by 28% year-on-year but it is up by 17% since the previous quarter
The current ratio has contracted by 22% YoY but it has grown by 22% from the previous quarter
Koss's debt is 100% lower than its equity
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.